Overview

Avoiding Neuromuscular Blockers to Reduce Complications

Status:
Suspended
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The goal of this study to evaluate whether eliminating the use of non-depolarizing neuromuscular blocking agents (NMBA) for maintenance of general anesthesia reduces postoperative pulmonary complications in higher risk patients.
Phase:
Phase 4
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Treatments:
Analgesics, Opioid
Anesthetics
Dexmedetomidine
Ketamine
Neuromuscular Blocking Agents
Propofol
Rocuronium